检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:黄波[1] 肖影群[1] 罗达亚[2] 章萍[1] 杨仙荷[1] 钟青梅[1] 王武[1] 姚迪[1]
机构地区:[1]南昌大学附属感染病医院病理科,江西南昌330002 [2]南昌大学基础医学院生物化学与分子生物学教研室,江西南昌330006
出 处:《中国病理生理杂志》2016年第2期363-370,共8页Chinese Journal of Pathophysiology
基 金:2011江西省卫生厅科技计划(No.20112043);2012年南昌市市校合作项目(洪财企[80]号)
摘 要:目的:探讨肝细胞癌中miR-375的表达及其调控的相关靶基因和信号通路。方法:采用原位杂交检测miR-375在人肝癌组织芯片的表达情况;人全基因组表达谱芯片检测4株肝癌细胞株;MAS生物信息学软件筛选miR-375调控靶基因及相关信号通路。结果:原位杂交结果显示miR-375在肝癌组织中的表达明显高于癌旁组织(P<0.05);人全基因组表达谱芯片结果分析显示4株转染miR-375的肝癌细胞的共上调基因有20个,共下调基因有17个;MAS生物信息学软件分析显示4株转染miR-375的肝癌细胞共有的上调信号通路有54条,下调信号通路有48条。结论:miR-375与肝细胞癌有密切的关系。对miR-375调控的肝细胞癌相关靶基因与信号通路进行多元化筛选,为后续全面深入的研究肝细胞癌发生发展的机制提供了便利。AIM: To investigate the expression of microRNA-375 (miR-375) in hepatocellular carcinoma (HCC) and to analyze the target genes and signaling pathways regulated by miR-375. METHODS: The expression of miR-375 was examined at tissue microarray of HCC by in situ hybridization. The whole human genome chip and bioinforma- tics analysis were applied to screen out the differential expression genes and signaling pathways in 4 HCC cell lines trans- fected with miR-375 mimic. RESULTS : In situ hybridization showed the expression of miR-375 in HCC tissues were obvi- ously higher than that in tumor-adjacent tissues ( P 〈 0. 05 ). There were 20 co-upregulated genes and 17 co-downregulated genes in all 4 cell lines. Bioinformatic analysis showed that there were 54 signaling pathways related to up-regulated genes and 48 signaling pathways related to down-regulated genes in all 4 cell lines. CONCLUSION: miR-375 may play a key role in the pathological process of HCC. The bioinformatic analysis is able to screen the target genes and signaling pathways regulated by miR-375 and to provide an explicit direction for further mechanism research on HCC.
关 键 词:肝细胞癌 MicroRNA-375 原位杂交 基因芯片
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.30